Immersive Virtual Reality in Simulation-based Bronchoscopy Training

NCT05078762 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2022-03-09

No results posted yet for this study

Summary

The purpose of this single-center randomized study is to investigate whether bronchoscopy training in an immersive Virtual Reality (iVR) environment will make the surgeon better at handling distractions and increase the quality of the bronchoscopy.

The participants will be stratified according to gender and randomized into two groups. Both groups will initially train on the bronchoscopy simulator without VR. Afterwards the intervention group will train in an iVR environment with Virtual Reality Goggles while using the bronchoscopy simulator, while the control group will train without VR goggles.

Afterwards both groups will be tested in the iVR environment in a test scenario

Conditions

  • Virtual Reality
  • Medical Education

Interventions

OTHER

Immersive Virtual Reality

Training in an iVR environment with Virtual Reality Goggles while using the bronchoscopy simulator, while the control group will train without VR goggles.

Sponsors & Collaborators

  • Copenhagen Academy for Medical Education and Simulation

    lead OTHER

Principal Investigators

  • Lars Konge, Professor, MD, PHD · Copenhagen Academy for Medical Education and Simulation

  • Flemming Bjerrum, MD, PhD · Copenhagen Academy for Medical Education and Simulation

  • Annarita G Andersen, BMed · Copenhagen Academy for Medical Education and Simulation

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-04
Primary Completion
2022-01-30
Completion
2022-02-28

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05078762 on ClinicalTrials.gov